{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-074485","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2022-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.317995+00:00","generated_at":"2026-06-24T22:54:50.015104+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Hepion Pharma annual meeting: equity plan & say-on-pay fail; 3 directors face majority withhold votes","bullets":["Proposal 3 (2022 Omnibus Equity Incentive Plan) failed: 11.0M for, 20.1M against.","Proposal 5 (say-on-pay) failed: 9.2M for, 21.6M against.","Directors Gary Jacob, John Brancaccio, and Timothy Block each received more withhold votes than for votes.","Proposal 4 (authorized share increase) adjourned to July 22, 2022 due to insufficient votes.","Proposal 2 (ratify BDO USA as auditor) passed with 31.1M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-074485","json":"https://secwatch.observer/filing/0001104659-22-074485.json","markdown":"https://secwatch.observer/filing/0001104659-22-074485.md","text":"https://secwatch.observer/filing/0001104659-22-074485.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/0001104659-22-074485-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/tm2219430d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:54:50.015104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}